Aisen PS - Search Results

1

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report.

Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R. Raman R, et al. Among authors: aisen ps. J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50. J Prev Alzheimers Dis. 2022. PMID: 35841239 Free PMC article.

2

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ. Aisen PS, et al. Neurology. 2000 Feb 8;54(3):588-93. doi: 10.1212/wnl.54.3.588. Neurology. 2000. PMID: 10680787 Clinical Trial.

3

A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease.

Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. Aisen PS, et al. Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):246-9. Am J Geriatr Psychiatry. 2003. PMID: 12611755 Clinical Trial.

4

Benchmarking a test of temporal orientation with data from american and taiwanese persons with Alzheimer's disease and american normal elderly.

Tractenberg RE, Weinstein M, Weiner MF, Aisen PS, Fuh JL, Goldman N, Chuang YL. Tractenberg RE, et al. Among authors: aisen ps. Neuroepidemiology. 2005;24(1-2):110-6. doi: 10.1159/000081610. Epub 2004 Oct 18. Neuroepidemiology. 2005. PMID: 15492486 Free PMC article.

5

ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI).

Walsh SP, Raman R, Jones KB, Aisen PS; Alzheimer's Disease Cooperative Study Group. Walsh SP, et al. Among authors: aisen ps. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S170-8. doi: 10.1097/01.wad.0000213879.55547.57. Alzheimer Dis Assoc Disord. 2006. PMID: 17135810 Clinical Trial.

6

Alzhemed: a potential treatment for Alzheimer's disease.

Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Aisen PS, et al. Curr Alzheimer Res. 2007 Sep;4(4):473-8. doi: 10.2174/156720507781788882. Curr Alzheimer Res. 2007. PMID: 17908052 Review.

7

Leon Thal and the therapeutic age of Alzheimer's disease.

Aisen PS. Aisen PS. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S4-6. doi: 10.1016/j.jalz.2007.12.001. Alzheimers Dement. 2008. PMID: 18631999 No abstract available.

8

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.

Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Fleisher AS, et al. Among authors: aisen ps. Arch Neurol. 2008 Aug;65(8):1031-8. doi: 10.1001/archneur.65.8.1031. Arch Neurol. 2008. PMID: 18695053 Free PMC article. Clinical Trial.

9

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ; Alzheimer Disease Cooperative Study. Aisen PS, et al. JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774. JAMA. 2008. PMID: 18854539 Free PMC article. Clinical Trial.

10

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Mormino EC, et al. Brain. 2009 May;132(Pt 5):1310-23. doi: 10.1093/brain/awn320. Epub 2008 Nov 28. Brain. 2009. PMID: 19042931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters